|
| Press Releases |
|
 |
|
| Monday, September 29, 2025 |
|
|
Hua Medicine Announces the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin |
| Hua Medicine (HKEX: 2552) announced that the Department of Health of the Hong Kong Special Administrative Region of China accepted a New Drug Application (NDA) for dorzagliatin, the world's first glucokinase activator (GKA) approved for the treatment of Type 2 diabetes (T2D). more info >> |
|
|
华领医药宣布中国香港卫生署药物办公室正式受理多格列艾汀新药上市许可申请 |
| 华领医药（"公司"，香港联交所股份代号：2552）宣布，中国香港特别行政区卫生署已正式受理多格列艾汀（dorzagliatin）的新药上市许可申请（NDA）。多格列艾汀是世界上第一个获批准用于治疗2型糖尿病（T2D）的葡萄糖激酶激活剂（GKA）。 more info >> |
|
|
華領醫藥宣佈中國香港衛生署藥物辦公室正式受理多格列艾汀新藥上市許可申請 |
| 華領醫藥（"公司"，香港聯交所股份代號：2552）宣佈，中國香港特別行政區衛生署已正式受理多格列艾汀（dorzagliatin）的新藥上市許可申請（NDA）。多格列艾汀是世界上第一個獲批准用于治療2型糖尿病（T2D）的葡萄糖激酶激活劑（GKA）。 more info >> |
|
| Thursday, August 28, 2025 |
|
|
Hua Medicine Announces 2025 Interim Results |
| Hua Medicine (the 'Company', HKEx: 2552) announced the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2025 (the 'Reporting Period'), as well as the Company's business progress during the first half of the year and future outlook. During the Reporting Period, the commercialization of the Company's core product, HuaTangNing'(dorzagliatin tablets), accelerated. The Company's independent operational capabilities improved significantly. more info >> |
|
|
華領醫藥公佈2025年中期業績 |
| 華領醫藥（"公司"，香港聯交所股份代號：2552）宣佈公司及其附屬公司截至2025年6月30日止六個月（"報告期"）未經審核的綜合業績，以及公司上半年業務進展與未來展望。報告期內，公司核心產品华堂宁(R)（多格列艾汀片）商業化加速，自主運營能力顯著提升，研發進展順利推進，財務表現實現突破性成長，為長期可持續發展奠定了堅實基礎。 more info >> |
|
|
华领医药公布2025年中期业绩 |
| 华领医药（"公司"，香港联交所股份代号：2552）宣布公司及其附属公司截至2025年6月30日止六个月（"报告期"）未经审核的综合业绩，以及公司上半年业务进展与未来展望。 more info >> |
|
| Monday, June 23, 2025 |
|
|
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis |
| Hua Medicine ("the Company", stock code: 2552.HK) announced today that the Company presented the latest research results of dorzagliatin, its global first-in-class glucokinase activator (GKA), at the 85th Scientific Sessions of the American Diabetes Association (ADA). more info >> |
|
|
華領醫藥在2025ADA科學年會公佈多格列艾汀與DPP-4抑制劑聯用在恢復血糖穩態的同時有望降低血脂 |
| 華領醫藥（“公司”，香港聯交所股份代號：2552.HK）今天宣佈，第85屆美國糖尿病協會（ADA）科學年會上，公司展示了其全球首創新藥葡萄糖激酶激活劑（GKA）多格列艾汀（dorzagliatin）的最新研究成果。 more info >> |
|
|
华领医药在2025ADA科学年会公布多格列艾汀与DPP-4抑制剂联用在恢复血糖稳态的同时有望降低血脂 |
| 华领医药（“公司”，香港联交所股份代号：2552.HK）今天宣布，第85届美国糖尿病协会（ADA）科学年会上，公司展示了其全球首创新药葡萄糖激酶激活剂（GKA）多格列艾汀（dorzagliatin）的最新研究成果。 more info >> |
|
| Friday, March 28, 2025 |
|
|
Hua Medicine Announces 2024 Annual Results |
| Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552) announced the audited full-year results of the Company and its subsidiaries for the year ended December 31, 2024 (the "Reporting Period"), along with the Company's business progress in 2024 and future business outlook. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Leapfrog Acquisition Corp Announces Pricing of $125,000,000 Initial Public Offering
Dec 5, 2025 18:50: JST
|
|
|
Leapfrog Acquisition Corp Announces Pricing of $125,000,000 Initial Public Offering
Dec 5, 2025 17:50 HKT/SGT
|
|
|
Business of IP Asia (BIP Asia) Forum and Entrepreneur Day open today
Dec 5, 2025 15:41 HKT/SGT
|
|
|
心系大埔火災災情 斯派柯急援300萬港元助重建
Dec 5, 2025 15:13 HKT/SGT
|
|
|
三菱造船と日本製鉄が低圧液化CO₂タンクの新規鋼材と熱処理（PWHT）省略技術を開発
Dec 5, 2025 11:30: JST
|
|
|
LEXUS、バッテリーEVスポーツカーのコンセプトモデル「Lexus LFA Concept」を世界初公開
Dec 5, 2025 11:20: JST
|
|
|
Business of IP Asia (BIP Asia) Forum and Entrepreneur Day open today
Dec 4, 2025 22:00: JST
|
|
|
Doubleview Extends High-Grade Domains at Hat: H099 Returns 438m of 0.40% CuEq Including 52m of 1.02% CuEq, Expanding Mineralization Envelope Around Conceptual Pit Vertically and Laterally
Dec 4, 2025 21:59 HKT/SGT
|
|
|
CaoCao Unveils '100 Cities, 100 Billion in 10 Years' Robotaxi Strategy, Officially Launches World's First 'Green Intelligent Mobility Hub'
Dec 4, 2025 21:00 HKT/SGT
|
|
|
曹操出行發佈Robotaxi「十年百城千億」戰略目標 全球首個「綠色智慧通行島」正式啟用
Dec 4, 2025 18:18 HKT/SGT
|
|
|
The Gourmet's Guide: Using Your TravelKon eSIM to Hunt for Japan's Best Ramen, Sushi, and Street Food
Dec 4, 2025 17:45 HKT/SGT
|
|
|
Spritzer Celebrates Global and Regional Brand Excellence 2025
Dec 4, 2025 12:45 HKT/SGT
|
|
|
Honda、新型「CR-V」の先行予約開始
Dec 4, 2025 11:30: JST
|
|
|
在聯泓格潤「超級工廠」看見綠色材料全鏈路
Dec 4, 2025 09:36 HKT/SGT
|
|
|
在联泓格润"超级工厂" 看见绿色材料全链路
Dec 4, 2025 09:14 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
